Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private

BSE5646.0084.5 (+1.52 %)

PREV CLOSE ( ) 5561.50

OPEN PRICE ( ) 5413.10

BID PRICE (QTY) 5642.35 (2)

OFFER PRICE (QTY) 5648.45 (9)

VOLUME 541

TODAY'S LOW / HIGH ( )5413.10 5646.00

52 WK LOW / HIGH ( )4498.9 5867.5

NSE5643.5088 (+1.58 %)

PREV CLOSE( ) 5555.50

OPEN PRICE ( ) 5555.50

BID PRICE (QTY) 5642.50 (35)

OFFER PRICE (QTY) 5643.50 (125)

VOLUME 30743

TODAY'S LOW / HIGH( ) 5555.50 5652.00

52 WK LOW / HIGH ( )4491.65 5868

Quarters

Select year

( in Million)

Particulars

Sep 2025

Jun 2025

Mar 2025

Dec 2024

Audited / UnAudited

UnAudited

Net Sales

40009.9

33711.4

31437.5

33742.8

Total Expenditure

30802.2

26320.9

27524.6

26148.9

PBIDT (Excl OI)

9207.7

7390.5

3912.9

7593.9

Other Income

1036.9

1364.9

1459.6

929.9

Operating Profit

10244.6

8755.4

5372.5

8523.8

Interest

350.2

297.8

284.2

360.3

Exceptional Items

129.3

0.00

PBDT

9894.4

8586.9

5088.3

8163.5

Depreciation

936.1

876.8

1124.9

852.8

Profit Before Tax

8958.3

7710.1

3963.4

7310.7

Tax

1162.3

1026.9

733.3

902.8

Provisions and contingencies

Profit After Tax

7796

6683.2

3230.1

6407.9

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

7796

6683.2

3230.1

6407.9

Minority Interest

-140.5

-36.5

-165.3

-149.7

Shares of Associates

-4.9

-4.1

-6.2

Other related items

Misc. Expenses Written off

Consolidated Net Profit

7650.6

6642.6

3058.6

6258.2

Equity Capital

239.1

Face Value (IN RS)

Reserves

Calculated EPS

63.99

55.56

25.58

52.34

Calculated EPS (Annualised)

255.97

222.25

102.33

209.39

No of Public Share Holdings

58351891

56151891

53651891

53010675

% of Public Share Holdings

48.8

46.96

44.87

44.34

PBIDTM% (Excl OI)

23.01

21.92

12.44

22.50

PBIDTM%

25.60

25.97

17.08

25.26

PBDTM%

24.72

25.47

16.18

24.19

PBTM%

22.39

22.87

12.60

21.66

PATM%

19.48

19.82

10.27

18.99

Notes

Risk Disclosures on Derivatives

Quarterly Results

ALKEM LABORATORIES LTD.